CCI approves stakes of Temasek and Goldman Sachs in PharmEasy
CCI approves stakes of Temasek and Goldman Sachs in PharmEasy
January 31 2024       CCI approves stakes of Temasek and Goldman Sachs in PharmEasy

CCI approved the subscription of PharmEasy's compulsory convertible preference shares (CCPS) by Goldman Sachs India, Temasek-owned MacRitchie Investments and EvolutionX, and CDPQ (Canadian pension fund). CCI also approved the additional shareholding of Prosus in API Holdings, PharmEasy's parent company.
 
For more, click here